Technical Analysis for GNMK - GenMark Diagnostics, Inc.

Grade Last Price % Change Price Change
grade C 6.87 -0.15% -0.01
GNMK closed down 0.15 percent on Monday, May 20, 2019, on 44 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical GNMK trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -0.15%
Down 3 Days in a Row Weakness -0.15%
Oversold Stochastic Weakness -0.15%
20 DMA Resistance Bearish -3.10%
50 DMA Resistance Bearish -3.10%

Older signals for GNMK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company's products include XT-8 system, an automated molecular diagnostic system that enables reference laboratories and hospitals to perform molecular diagnostic tests. It also offers 8 diagnostic tests for use with its XT-8 system that includes Cystic Fibrosis Genotyping Test, which detects a panel of mutations associated with cystic fibrosis; Warfarin Sensitivity test that determines an individual's ability to metabolize the oral anticoagulant warfarin; Thrombophilia Risk Test, which detects an individual's increased risk of blood clots; and Respiratory Viral Panel test that simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illnesses. The company's diagnostic tests also include Hepatitis C Virus Genotyping test for the detection and typing/subtyping of HCV; 3A4/3A5 Genotyping test designed for the detection and genotyping of the alleles of the CYP450 3A4 gene locus and CYP450 3A5 gene locus; and 2C19 Genotyping test for the detection and genotyping alleles of the cytochrome P450 (CYP450) 2C19 gene locus. In addition, the company engages in developing a NexGen system to integrate automated nucleic acid extraction and amplification with its eSensor detection technology to enable technicians to place a patient sample into test cartridge and obtain results without any additional steps. Genmark Diagnostics, Inc. is headquartered in Carlsbad, California.
Biotechnology Manufacturing Biology Genetics Diagnostic Tests Medical Genetics Medical Tests Cystic Fibrosis Molecular Diagnostics Genotyping HCV Blood Clots Innogenetics
Is GNMK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.81
52 Week Low 3.58
Average Volume 289,791
200-Day Moving Average 6.5052
50-Day Moving Average 7.2802
20-Day Moving Average 7.3835
10-Day Moving Average 7.269
Average True Range 0.3293
ADX 15.58
+DI 14.7252
-DI 23.6944
Chandelier Exit (Long, 3 ATRs ) 7.1821
Chandelier Exit (Short, 3 ATRs ) 7.6879
Upper Bollinger Band 8.0352
Lower Bollinger Band 6.7318
Percent B (%b) 0.11
BandWidth 17.652875
MACD Line -0.067
MACD Signal Line 0.0262
MACD Histogram -0.0932
Fundamentals Value
Market Cap 375.57 Million
Num Shares 54.7 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -5.63
Price-to-Sales 8.35
Price-to-Book 4.53
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.17
Resistance 3 (R3) 7.15 7.02 7.12
Resistance 2 (R2) 7.02 6.95 7.04 7.10
Resistance 1 (R1) 6.95 6.90 6.99 6.97 7.09
Pivot Point 6.82 6.82 6.84 6.84 6.82
Support 1 (S1) 6.75 6.75 6.79 6.77 6.65
Support 2 (S2) 6.62 6.70 6.64 6.64
Support 3 (S3) 6.55 6.62 6.62
Support 4 (S4) 6.57